Page last updated: 2024-11-06

mitomycin and Genetic Predisposition

mitomycin has been researched along with Genetic Predisposition in 27 studies

Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.

Research Excerpts

ExcerptRelevanceReference
"In patients with superficial bladder cancer, the occurrence of primary carcinoma in situ was significantly greater in patients with the AA genotype compared with those with the GA or GG genotypes (P = 0."5.32Polymorphism within the cyclin D1 gene is associated with an increased risk of carcinoma in situ in patients with superficial bladder cancer. ( Habuchi, T; Higashi, S; Ito, M; Kamoto, T; Nishiyama, H; Ogawa, O; Tsuchiya, N; Wang, L; Watanabe, J, 2004)
"Hydrogen-rich water has a significant protective effect on OGD/R-causing HT22 cell injury, and the mechanism may be related to the inhibition of autophagy."4.40Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19. ( , 2023)
" A total of 21 genetic variants were studied in 35 breast cancer patients treated with 5-FluoroUracil, mitomycin (FUMI) and in a similar cohort of 90 doxorubicin treated breast cancer patients."3.74Pathway based analysis of SNPs with relevance to 5-FU therapy: relation to intratumoral mRNA expression and survival. ( Alnaes, GI; Børresen-Dale, AL; Hihn, B; Kristensen, VN; Liestøl, K; Lingjaerde, OC; Lønning, PE; Nordgard, SH; Sørlie, T; Tsalenko, A, 2008)
" In chromosomal breakage assays, all control cells were mitomycin C (MMC) resistant, but eight samples (five of the six high-risk and three of the eight ovarian cancer) were hypersensitive."3.73Cytogenetic instability in ovarian epithelial cells from women at risk of ovarian cancer. ( Akkari, Y; Ameziane, N; Bagby, GC; Bale, AE; Cain, JM; Cappuccini, F; Errami, A; Hays, LE; Keeble, W; Liu, HY; Olson, SB; Pejovic, T; Rathbun, RK; Rodgers, WH; Thuillier, P; Torimaru, Y; Yates, JE; Zwaan, CM, 2006)
" To assess DNA repair for breast cancer susceptibility, we developed a modified HCR assay using a plasmid containing a firefly luciferase gene damaged by mitomycin C (MMC), which forms interstrand cross-link (ICL) adducts."3.72Repair of mitomycin C cross-linked DNA in mammalian cells measured by a host cell reactivation assay. ( Ahn, B; Kang, D; Kim, H; Wei, Q, 2004)
"Of 1774 patients with breast cancer given mitoxantrone (MTZ) with methotrexate (n = 492) or with methotrexate and mitomycin C (n = 1282), nine developed MDS/AML after a median of 2."3.70Secondary myelodysplastic syndrome/acute myeloid leukaemia following mitoxantrone-based therapy for breast carcinoma. ( Ashley, S; Kuan, A; Kulkarni, S; Mehta, J; Mitchell, P; Powles, R; Powles, T; Saso, R; Swansbury, GJ; Treleaven, J, 2000)
"Oral squamous cell carcinoma (OSCC) may develop in young adults."1.43Sensitivity to chromosomal breakage as risk factor in young adults with oral squamous cell carcinoma. ( Braakhuis, BJ; Brakenhoff, RH; Flach, GB; Graveland, AP; Joenje, H; Leemans, CR; Nieuwint, AW; Oostra, AB, 2016)
"Leukemias and squamous cell carcinomas (SCCs) are the most predominant FA-associated cancers, with the latter exhibiting markedly early disease onset and aggressiveness."1.35Fanconi anemia deficiency stimulates HPV-associated hyperplastic growth in organotypic epithelial raft culture. ( Cha, E; Duensing, S; Higginbotham, JM; Hoskins, EE; Kelly, P; Morris, TA; Spardy, N; Wells, SI; Wikenheiser-Brokamp, KA; Williams, DA, 2009)
"There is evidence to suggest that the breast cancer predisposing gene, BRCA1, is involved in cell cycle control and the response to damage but mouse brca1+/- heterozygotes have no distinctive phenotype."1.32Primary fibroblasts from BRCA1 heterozygotes display an abnormal G1/S cell cycle checkpoint following UVA irradiation but show normal levels of micronuclei following oxidative stress or mitomycin C treatment. ( Eccles, D; Eeles, R; Latham, H; McMillan, TJ; Peacock, JH; Shorrocks, J; Tobi, SE, 2004)
"In patients with superficial bladder cancer, the occurrence of primary carcinoma in situ was significantly greater in patients with the AA genotype compared with those with the GA or GG genotypes (P = 0."1.32Polymorphism within the cyclin D1 gene is associated with an increased risk of carcinoma in situ in patients with superficial bladder cancer. ( Habuchi, T; Higashi, S; Ito, M; Kamoto, T; Nishiyama, H; Ogawa, O; Tsuchiya, N; Wang, L; Watanabe, J, 2004)

Research

Studies (27)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (3.70)18.2507
2000's14 (51.85)29.6817
2010's10 (37.04)24.3611
2020's2 (7.41)2.80

Authors

AuthorsStudies
Frost, MG1
Mazloumi Aboukheili, AM1
Toth, R1
Walden, H1
Gayarre, J1
Martín-Gimeno, P1
Osorio, A1
Paumard, B1
Barroso, A1
Fernández, V1
de la Hoya, M1
Rojo, A1
Caldés, T1
Palacios, J1
Urioste, M1
Benítez, J2
García, MJ1
Colombo, M1
Lòpez-Perolio, I1
Meeks, HD1
Caleca, L1
Parsons, MT1
Li, H1
De Vecchi, G1
Tudini, E1
Foglia, C1
Mondini, P1
Manoukian, S1
Behar, R1
Garcia, EBG1
Meindl, A1
Montagna, M1
Niederacher, D1
Schmidt, AY1
Varesco, L1
Wappenschmidt, B1
Bolla, MK1
Dennis, J1
Michailidou, K1
Wang, Q1
Aittomäki, K1
Andrulis, IL1
Anton-Culver, H1
Arndt, V1
Beckmann, MW1
Beeghly-Fadel, A1
Boeckx, B1
Bogdanova, NV1
Bojesen, SE1
Bonanni, B1
Brauch, H1
Brenner, H1
Burwinkel, B1
Chang-Claude, J1
Conroy, DM1
Couch, FJ2
Cox, A2
Cross, SS1
Czene, K1
Devilee, P1
Dörk, T1
Eriksson, M1
Fasching, PA1
Figueroa, J1
Fletcher, O1
Flyger, H1
Gabrielson, M1
García-Closas, M1
Giles, GG1
González-Neira, A1
Guénel, P1
Haiman, CA1
Hall, P1
Hamann, U1
Hartman, M1
Hauke, J1
Hollestelle, A1
Hopper, JL1
Jakubowska, A1
Jung, A1
Kosma, VM1
Lambrechts, D1
Le Marchand, L1
Lindblom, A1
Lubinski, J1
Mannermaa, A1
Margolin, S1
Miao, H1
Milne, RL1
Neuhausen, SL1
Nevanlinna, H1
Olson, JE1
Peterlongo, P1
Peto, J1
Pylkäs, K1
Sawyer, EJ1
Schmidt, MK1
Schmutzler, RK1
Schneeweiss, A1
Schoemaker, MJ1
See, MH1
Southey, MC1
Swerdlow, A1
Teo, SH1
Toland, AE1
Tomlinson, I1
Truong, T1
van Asperen, CJ1
van den Ouweland, AMW1
van der Kolk, LE1
Winqvist, R1
Yannoukakos, D1
Zheng, W1
Dunning, AM1
Easton, DF1
Henderson, A1
Hogervorst, FBL1
Izatt, L1
Offitt, K1
Side, LE1
van Rensburg, EJ1
Embrace, S1
Hebon, S1
McGuffog, L1
Antoniou, AC1
Chenevix-Trench, G1
Spurdle, AB1
Goldgar, DE1
Hoya, M1
Radice, P1
Xu, X1
Zhang, Y1
Zhao, S1
Bian, Y1
Ning, Y1
Qin, Y1
Moiseyenko, VM1
Chubenko, VA1
Moiseyenko, FV1
Zhabina, AS1
Gorodnova, TV1
Komarov, YI1
Bogdanov, AA1
Sokolenko, AP1
Imyanitov, EN1
Deng, X1
Zhang, X1
Cheng, Y1
Yang, X1
Zhao, R1
Liu, X1
Li, X1
Qin, C1
Lu, Q1
Yin, C1
El Hamichi, S1
Messaoudi, R1
Belmalih, M1
Iferkhass, S1
Zerrouk, R1
Reda, K1
Oubaaz, A1
Braakhuis, BJ1
Nieuwint, AW1
Oostra, AB1
Joenje, H1
Flach, GB1
Graveland, AP1
Brakenhoff, RH1
Leemans, CR1
Matsuzaki, K1
Borel, V1
Adelman, CA1
Schindler, D1
Boulton, SJ1
Hoskins, EE1
Morris, TA1
Higginbotham, JM1
Spardy, N1
Cha, E1
Kelly, P1
Williams, DA1
Wikenheiser-Brokamp, KA1
Duensing, S1
Wells, SI1
Auerbach, AD1
Hayakawa, T1
Zhang, F1
Hayakawa, N1
Ohtani, Y1
Shinmyozu, K1
Nakayama, J1
Andreassen, PR1
Wark, L1
Novak, D1
Sabbaghian, N1
Amrein, L1
Jangamreddy, JR1
Cheang, M1
Pouchet, C1
Aloyz, R1
Foulkes, WD1
Mai, S1
Tischkowitz, M1
Stewart, G1
Elledge, SJ1
Shorrocks, J1
Tobi, SE1
Latham, H1
Peacock, JH1
Eeles, R1
Eccles, D1
McMillan, TJ1
Han, J1
Colditz, GA1
Samson, LD1
Hunter, DJ1
McPherson, JP1
Lemmers, B1
Chahwan, R1
Pamidi, A1
Migon, E1
Matysiak-Zablocki, E1
Moynahan, ME1
Essers, J1
Hanada, K1
Poonepalli, A1
Sanchez-Sweatman, O1
Khokha, R1
Kanaar, R1
Jasin, M1
Hande, MP1
Hakem, R1
Ito, M1
Habuchi, T1
Watanabe, J1
Higashi, S1
Nishiyama, H1
Wang, L1
Tsuchiya, N1
Kamoto, T1
Ogawa, O1
Ahn, B1
Kang, D1
Kim, H1
Wei, Q1
Wu, K1
Hinson, SR1
Ohashi, A1
Farrugia, D1
Wendt, P1
Tavtigian, SV1
Deffenbaugh, A1
Goldgar, D1
Pejovic, T1
Yates, JE1
Liu, HY1
Hays, LE1
Akkari, Y1
Torimaru, Y1
Keeble, W1
Rathbun, RK1
Rodgers, WH1
Bale, AE1
Ameziane, N1
Zwaan, CM1
Errami, A1
Thuillier, P1
Cappuccini, F1
Olson, SB1
Cain, JM1
Bagby, GC1
Nordgard, SH1
Alnaes, GI1
Hihn, B1
Lingjaerde, OC1
Liestøl, K1
Tsalenko, A1
Sørlie, T1
Lønning, PE1
Børresen-Dale, AL1
Kristensen, VN1
Liou, SH1
Gu, TL1
Chen, CJ1
Yu, VP1
Koehler, M1
Steinlein, C1
Schmid, M1
Hanakahi, LA1
van Gool, AJ1
West, SC1
Venkitaraman, AR1
Saso, R1
Kulkarni, S1
Mitchell, P1
Treleaven, J1
Swansbury, GJ1
Mehta, J1
Powles, R1
Ashley, S1
Kuan, A1
Powles, T1
Rafii, S1
O'Regan, P1
Xinarianos, G1
Azmy, I1
Stephenson, T1
Reed, M1
Meuth, M1
Thacker, J1

Reviews

2 reviews available for mitomycin and Genetic Predisposition

ArticleYear
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
    Science & sports, 2023, Apr-04

    Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp

2023
Fanconi anemia and its diagnosis.
    Mutation research, 2009, Jul-31, Volume: 668, Issue:1-2

    Topics: Congenital Abnormalities; DNA Damage; Endocrine System Diseases; Epoxy Compounds; Fanconi Anemia; Ge

2009

Trials

1 trial available for mitomycin and Genetic Predisposition

ArticleYear
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
    Science & sports, 2023, Apr-04

    Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp

2023

Other Studies

25 other studies available for mitomycin and Genetic Predisposition

ArticleYear
Characterization of FANCL variants observed in patient cancer cells.
    Bioscience reports, 2020, 06-26, Volume: 40, Issue:6

    Topics: Antineoplastic Agents, Alkylating; Biomarkers, Tumor; Bone Neoplasms; Cell Line, Tumor; Cell Surviva

2020
Characterisation of the novel deleterious RAD51C p.Arg312Trp variant and prioritisation criteria for functional analysis of RAD51C missense changes.
    British journal of cancer, 2017, Sep-26, Volume: 117, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Algorithms; Breast Neoplasms; Carcinoma; Case-Control Studies; Cell

2017
The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity.
    Human mutation, 2018, Volume: 39, Issue:5

    Topics: Base Sequence; BRCA2 Protein; Calibration; Cell Line; Exons; Female; Genetic Predisposition to Disea

2018
Mutational analysis of theFAM175A gene in patients with premature ovarian insufficiency.
    Reproductive biomedicine online, 2019, Volume: 38, Issue:6

    Topics: Adult; BRCA1 Protein; Carrier Proteins; DNA Damage; DNA Mutational Analysis; DNA Repair; Female; Gen

2019
Evidence for clinical efficacy of mitomycin C in heavily pretreated ovarian cancer patients carrying germ-line BRCA1 mutation.
    Medical oncology (Northwood, London, England), 2014, Volume: 31, Issue:10

    Topics: Adult; Aged; Alkylating Agents; BRCA1 Protein; Female; Genetic Predisposition to Disease; Germ-Line

2014
XRCC1 polymorphisms associated with survival among Chinese bladder cancer patients receiving epirubicin and mitomycin C.
    Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2015, Volume: 36, Issue:6

    Topics: Aged; Alleles; Biomarkers, Pharmacological; China; Disease-Free Survival; DNA-Binding Proteins; Epir

2015
Bilateral enucleation avoided by excision with mitomycin C for bilateral infiltrating conjunctival squamous cell carcinoma in a girl with xeroderma pigmentosum.
    Journal francais d'ophtalmologie, 2015, Volume: 38, Issue:7

    Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Child; Combined Modality Therapy; Conjunctival Neop

2015
Sensitivity to chromosomal breakage as risk factor in young adults with oral squamous cell carcinoma.
    Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 2016, Volume: 45, Issue:3

    Topics: Adult; Carcinoma, Squamous Cell; Chromosome Breakage; DNA Damage; Fanconi Anemia; Female; Genetic Pr

2016
FANCJ suppresses microsatellite instability and lymphomagenesis independent of the Fanconi anemia pathway.
    Genes & development, 2015, Dec-15, Volume: 29, Issue:24

    Topics: Animals; Antineoplastic Agents; Basic-Leucine Zipper Transcription Factors; Camptothecin; Cell Line;

2015
Fanconi anemia deficiency stimulates HPV-associated hyperplastic growth in organotypic epithelial raft culture.
    Oncogene, 2009, Feb-05, Volume: 28, Issue:5

    Topics: Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Cell Line, Transformed; Cell Proliferation; C

2009
MRG15 binds directly to PALB2 and stimulates homology-directed repair of chromosomal breaks.
    Journal of cell science, 2010, Apr-01, Volume: 123, Issue:Pt 7

    Topics: Breast Neoplasms; Chromatin; Chromosome Breakage; Comet Assay; Cross-Linking Reagents; DNA; DNA Repa

2010
Heterozygous mutations in the PALB2 hereditary breast cancer predisposition gene impact on the three-dimensional nuclear organization of patient-derived cell lines.
    Genes, chromosomes & cancer, 2013, Volume: 52, Issue:5

    Topics: Adolescent; Adult; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, In

2013
The two faces of BRCA2, a FANCtastic discovery.
    Molecular cell, 2002, Volume: 10, Issue:1

    Topics: Animals; BRCA2 Protein; DNA Damage; DNA Repair; Fanconi Anemia; Fanconi Anemia Complementation Group

2002
Primary fibroblasts from BRCA1 heterozygotes display an abnormal G1/S cell cycle checkpoint following UVA irradiation but show normal levels of micronuclei following oxidative stress or mitomycin C treatment.
    International journal of radiation oncology, biology, physics, 2004, Feb-01, Volume: 58, Issue:2

    Topics: Alkylating Agents; Breast Neoplasms; Cell Cycle; DNA Damage; Fibroblasts; G1 Phase; Genes, BRCA1; Ge

2004
Polymorphisms in DNA double-strand break repair genes and skin cancer risk.
    Cancer research, 2004, May-01, Volume: 64, Issue:9

    Topics: Adult; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Case-Control Studies; Cell Survival; DNA Dam

2004
Involvement of mammalian Mus81 in genome integrity and tumor suppression.
    Science (New York, N.Y.), 2004, Jun-18, Volume: 304, Issue:5678

    Topics: Alleles; Animals; Chromosome Aberrations; DNA Damage; DNA-Binding Proteins; Embryo, Mammalian; Embry

2004
Polymorphism within the cyclin D1 gene is associated with an increased risk of carcinoma in situ in patients with superficial bladder cancer.
    Urology, 2004, Volume: 64, Issue:1

    Topics: Aged; Alternative Splicing; Antineoplastic Agents, Alkylating; BCG Vaccine; Carcinoma in Situ; Carci

2004
Repair of mitomycin C cross-linked DNA in mammalian cells measured by a host cell reactivation assay.
    Molecules and cells, 2004, Oct-31, Volume: 18, Issue:2

    Topics: Animals; Breast Neoplasms; Cell Line; Cross-Linking Reagents; DNA Damage; DNA Repair; Fireflies; Gen

2004
Functional evaluation and cancer risk assessment of BRCA2 unclassified variants.
    Cancer research, 2005, Jan-15, Volume: 65, Issue:2

    Topics: Animals; BRCA2 Protein; Centrosome; Chromosome Segregation; Cross-Linking Reagents; DNA, Complementa

2005
Cytogenetic instability in ovarian epithelial cells from women at risk of ovarian cancer.
    Cancer research, 2006, Sep-15, Volume: 66, Issue:18

    Topics: Adult; Aged; Chromosome Breakage; DNA Methylation; DNA, Complementary; Epithelial Cells; Fanconi Ane

2006
Pathway based analysis of SNPs with relevance to 5-FU therapy: relation to intratumoral mRNA expression and survival.
    International journal of cancer, 2008, Aug-01, Volume: 123, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antibiotics, Antineoplastic; Antimetabolites,

2008
Hypersensitivity to mitomycin C-induced sister chromatid exchange as a biomarker of past exposure to arsenic.
    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 1996, Volume: 5, Issue:2

    Topics: Aged; Arsenic; Biomarkers; Carcinogens; Environmental Exposure; Feasibility Studies; Female; Fresh W

1996
Gross chromosomal rearrangements and genetic exchange between nonhomologous chromosomes following BRCA2 inactivation.
    Genes & development, 2000, Jun-01, Volume: 14, Issue:11

    Topics: Animals; Annexin A5; BRCA2 Protein; Cells, Cultured; Chromosome Aberrations; Chromosomes; Cross-Link

2000
Secondary myelodysplastic syndrome/acute myeloid leukaemia following mitoxantrone-based therapy for breast carcinoma.
    British journal of cancer, 2000, Volume: 83, Issue:1

    Topics: Acute Disease; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neopl

2000
A potential role for the XRCC2 R188H polymorphic site in DNA-damage repair and breast cancer.
    Human molecular genetics, 2002, Jun-01, Volume: 11, Issue:12

    Topics: Aged; Amino Acid Substitution; Breast Neoplasms; Cell Survival; DNA Repair; DNA-Binding Proteins; Fe

2002